Pheast Therapeutics logo

Pheast Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
4
Total Funding
$100.6M
Investors
4 investors across all rounds
AV
Alexandria Venture Investments
OTHER
AV
ARCH Venture Partners
OTHER
CC
Catalio Capital Management
VENTURE_CAPITAL
R
Rsquared
Explore More Data
Detailed analysis for Pheast Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Pheast Therapeutics Leadership & Investors

Pheast Therapeutics is led by a team of experienced leaders. The company has attracted investment from 4 institutional and strategic investors.

Who Has Invested in Pheast Therapeutics?

Pheast Therapeutics has raised $100.6M from 4 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Pheast Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.